Cambridge, 29 August 2019: Feedback plc (AIM: FDBK, "Feedback" or the "Company") announces that at the general meeting of the Company held earlier today, all resolutions were duly passed, including resolutions 1 and 2 pertaining to the Company's placing and subscription.
The proxy voting results of the resolutions are included below:
% of votes cast
% of votes cast
% of votes cast
Total votes cast
*"Votes For" include votes giving the Chairman discretion.
Total Voting Rights
Further to the announcement on 12 August 2019, Admission of the New Ordinary Shares is expected to take place at 8:00 a.m. on 30 August 2019.
On Admission, the issued share capital of the Company will consist of 539,949,917 Ordinary Shares with one voting right each. The Company does not hold any ordinary shares in treasury. Therefore, the total number of ordinary shares and voting rights in the Company will be 539,949,917. With effect from Admission, this figure may be used by Shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.
Capitalised terms used but not defined in this announcement shall have the meanings given to such terms in the section headed 'Definitions' in the Company's announcement of 12 August 2019.
Feedback plc (AIM: FDBK) is a specialist medical imaging technology company providing innovative software and systems, through its fully-owned trading subsidiary, Feedback Medical Limited. Its products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer. Feedback Medical works with customers globally from headquarters in the internationally renowned scientific hub of Cambridge, UK. Its proprietary technologies are TexRAD®, the quantitative texture analysis tool and Cadran, a picture archiving communication system (PACS). The Company has recently announced the launch of its new messaging and image transfer product Bleepa™.For more information, see www.fbk.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
Create your account: sign up and get ahead on news and events
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
Feedback PLC's (LON:FDBK) Tom Oakley caught up with Proactive London's Andrew Scott following the recent NHS Expo where they were showcasing the new Bleepa app.
''We had a great time, it was fantastic to have the product validated by all sorts of people from within the NHS as well as...